Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC.
Leroy T, Monnet E, Guerzider S, Jacoulet P, De Bari B, Falcoz PE, Gainet-Brun M, Lahourcade J, Alfreijat F, Almotlak H, Adotevi O, Pernet D, Polio JC, Desmarets M, Woronoff AS, Westeel V. Leroy T, et al. Among authors: gainet brun m. Lung Cancer. 2019 Nov;137:23-30. doi: 10.1016/j.lungcan.2019.09.001. Epub 2019 Sep 3. Lung Cancer. 2019. PMID: 31521979
Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer.
Eberst G, Vernerey D, Laheurte C, Meurisse A, Kaulek V, Cuche L, Jacoulet P, Almotlak H, Lahourcade J, Gainet-Brun M, Fabre E, Le Pimpec-Barthes F, Adotevi O, Westeel V. Eberst G, et al. Among authors: gainet brun m. BMC Cancer. 2022 May 11;22(1):529. doi: 10.1186/s12885-022-09628-8. BMC Cancer. 2022. PMID: 35546670 Free PMC article.
[Bevacizumab and lung cancer: eligible patients in daily practice].
Lagnien-Gaume V, Jehl J, Manzoni P, Jacoulet P, Gainet-Brun M, Metzger F, Pernet D, Polio JC, Pugin JF, Corgne J, Amoros C, Dalphin JC, Westeel V. Lagnien-Gaume V, et al. Among authors: gainet brun m. Rev Mal Respir. 2011 Jan;28(1):25-31. doi: 10.1016/j.rmr.2010.05.016. Epub 2011 Jan 17. Rev Mal Respir. 2011. PMID: 21277471 French.
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.
Adotévi O, Vernerey D, Jacoulet P, Meurisse A, Laheurte C, Almotlak H, Jacquin M, Kaulek V, Boullerot L, Malfroy M, Orillard E, Eberst G, Lagrange A, Favier L, Gainet-Brun M, Doucet L, Teixeira L, Ghrieb Z, Clairet AL, Guillaume Y, Kroemer M, Hocquet D, Moltenis M, Limat S, Quoix E, Mascaux C, Debieuvre D, Fagnoni-Legat C, Borg C, Westeel V. Adotévi O, et al. Among authors: gainet brun m. J Clin Oncol. 2023 Jan 10;41(2):373-384. doi: 10.1200/JCO.22.00096. Epub 2022 Sep 7. J Clin Oncol. 2023. PMID: 36070539 Clinical Trial.